Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism

S Bucharles, SH Barberato, AEM Stinghen… - Journal of Renal …, 2012 - Elsevier
INTRODUCTION: Vitamin D (25-hydroxyvitamin D, 25 (OH) D) deficiency, hypovitaminosis
D, is highly prevalent in chronic kidney disease patients and is potentially involved with …

[HTML][HTML] Prognostic value of controlling nutritional status on clinical and survival outcomes in cancer patients treated with immunotherapy

J Zhang, M Li, L Zhang, T Kuang, J Yu, W Wang - Scientific Reports, 2023 - nature.com
Cancer is a leading cause of death globally. Immunotherapy has shown promise in treating
various types of cancer, but its effectiveness varies among patients. The Controlling …

Malnutrition is associated with hyperinflammation and immunosuppression in COVID‐19 patients: a prospective observational study

H Liu, L Zhou, H Wang, X Wang, G Qu… - Nutrition in Clinical …, 2021 - Wiley Online Library
Background Coronavirus disease 2019 (COVID‐19) is spreading globally and has caused
many deaths. This study investigated, for the first time, COVID‐19 patients' nutrition status …

Plasma protein carbonyls as biomarkers of oxidative stress in chronic kidney disease, dialysis, and transplantation

G Colombo, F Reggiani, C Angelini… - Oxidative Medicine …, 2020 - Wiley Online Library
Accumulating evidence indicates that oxidative stress plays a role in the pathophysiology of
chronic kidney disease (CKD) and its progression; during renal replacement therapy …

Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients

H Honda, M Ueda, S Kojima, S Mashiba, T Michihata… - Atherosclerosis, 2012 - Elsevier
BACKGROUND AND OBJECTIVES: Here, we assessed the impact of oxidized high-density
lipoprotein (oxHDL), dysfunctional HDL, on mortality and cardiovascular disease (CVD) …

Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability

L D'Marco, A Bellasi, P Raggi - Disease markers, 2015 - Wiley Online Library
The high incidence of cardiovascular events in chronic kidney disease (CKD) warrants an
accurate evaluation of risk aimed at reducing the burden of disease and its consequences …

Serum calcification propensity and fetuin-A: biomarkers of cardiovascular disease in kidney transplant recipients

A Bostom, A Pasch, T Madsen, MB Roberts… - American journal of …, 2018 - karger.com
Abstract Background:“T50,” shortened transformation time from primary to secondary
calciprotein particles may reflect deranged mineral metabolism predisposing to vascular …

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)

A Saremi, RJ Anderson, P Luo, TE Moritz… - Atherosclerosis, 2009 - Elsevier
AIMS: The aim of the present study was to investigate the association of high-sensitivity C-
reactive protein (CRP), interleukin-6 (IL-6) and lipoprotein-associated phospholipase A2 (Lp …

Effect of L-carnitine supplementation on inflammatory markers and serum glucose in hemodialysis children: a randomized, placebo-controlled clinical trial

F Hamedi-Kalajahi, H Imani, SY Mojtahedi… - Journal of Renal …, 2022 - Elsevier
Objectives Chronic inflammation is present in a high proportion of the chronic kidney
disease (CKD) population, which can increase the risk of cardiovascular disease. Moreover …

[HTML][HTML] High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)

A Bruchfeld, AR Qureshi, B Lindholm, P Barany… - Molecular …, 2008 - Springer
Chronic kidney disease (CKD) is associated with inflammation and malnutrition and carries
a markedly increased risk of cardiovascular disease (CVD). High Mobility Group Box Protein …